Tech Company Financing Transactions

Scorpion Therapeutics Funding Round

Boxer Capital, EcoR1 Capital Management and Omega Funds joined a $162 million Series B funding round for Scorpion Therapeutics. The round was announced by the company on 1/8/2021.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

888 Boylston St. 1111
Boston, MA 02199
USA

Phone

(212) 841-1015

Website

www.scorpiontx.com

Email Address

[email protected]

Overview

At Scorpion Therapeutics, we are working to expand the reach of precision medicine to more people with cancer, including cancers that are untreatable or treatment-resistant today. We are moving with equal parts urgency and rigor to change the status quo, drawing on our team's expertise and drive to accelerate our impact on patients.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Gary Glick

        

Chief Scientific Officer

Darrin Stuart

        

Executive Vice President

Erica Jackson

        

VP - Bus. Development

Lina Gugucheva

        

VP - General Counsel

Joseph Campisi

        

VP - Human Resources

Amanda Valentino

        

VP - Operations

Adam Friedman

        

Browse more venture capital transactions:

Prev: 1/8/2021: Spectrum Effect venture capital transaction
Next: 1/8/2021: Kira Pharmaceuticals venture capital transaction

Share this article

Where The Data Comes From

We record funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary